154 related articles for article (PubMed ID: 36694108)
1. Individual frailty excess hazard models in cancer epidemiology.
Rubio FJ; Putter H; Belot A
Stat Med; 2023 Mar; 42(7):1066-1081. PubMed ID: 36694108
[TBL] [Abstract][Full Text] [Related]
2. A tutorial on frailty models.
Balan TA; Putter H
Stat Methods Med Res; 2020 Nov; 29(11):3424-3454. PubMed ID: 32466712
[TBL] [Abstract][Full Text] [Related]
3. Extended excess hazard models for spatially dependent survival data.
Amaral AVR; Rubio FJ; Quaresma M; Rodríguez-Cortés FJ; Moraga P
Stat Methods Med Res; 2024 Apr; 33(4):681-701. PubMed ID: 38444377
[TBL] [Abstract][Full Text] [Related]
4. Weighted Lindley frailty model: estimation and application to lung cancer data.
Mota A; Milani EA; Calsavara VF; Tomazella VLD; Leão J; Ramos PL; Ferreira PH; Louzada F
Lifetime Data Anal; 2021 Oct; 27(4):561-587. PubMed ID: 34331190
[TBL] [Abstract][Full Text] [Related]
5. A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates.
Charvat H; Remontet L; Bossard N; Roche L; Dejardin O; Rachet B; Launoy G; Belot A;
Stat Med; 2016 Aug; 35(18):3066-84. PubMed ID: 26924122
[TBL] [Abstract][Full Text] [Related]
6. Impact of model misspecification in shared frailty survival models.
Gasparini A; Clements MS; Abrams KR; Crowther MJ
Stat Med; 2019 Oct; 38(23):4477-4502. PubMed ID: 31328285
[TBL] [Abstract][Full Text] [Related]
7. Use of shared gamma frailty model in analysis of survival data in twins.
Mwikali Muli A; Gusnanto A; Houwing-Duistermaat J
Theor Biol Forum; 2021 Jan; 114(1-2):45-58. PubMed ID: 35502730
[TBL] [Abstract][Full Text] [Related]
8. A relaxation of the gamma frailty (Burr) model.
Perperoglou A; van Houwelingen HC; Henderson R
Stat Med; 2006 Dec; 25(24):4253-66. PubMed ID: 16921549
[TBL] [Abstract][Full Text] [Related]
9. Survival models induced by zero-modified power series discrete frailty: Application with a melanoma data set.
Molina KC; Calsavara VF; Tomazella VD; Milani EA
Stat Methods Med Res; 2021 Aug; 30(8):1874-1889. PubMed ID: 33955295
[TBL] [Abstract][Full Text] [Related]
10. Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
Patson N; Mukaka M; Kazembe L; Eijkemans MJC; Mathanga D; Laufer MK; Chirwa T
BMC Med Res Methodol; 2022 Jan; 22(1):24. PubMed ID: 35057743
[TBL] [Abstract][Full Text] [Related]
11. Nonproportional hazards and unobserved heterogeneity in clustered survival data: When can we tell the difference?
Balan TA; Putter H
Stat Med; 2019 Aug; 38(18):3405-3420. PubMed ID: 31050028
[TBL] [Abstract][Full Text] [Related]
12. Dynamic frailty models based on compound birth-death processes.
Putter H; van Houwelingen HC
Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
[TBL] [Abstract][Full Text] [Related]
13. On models for the estimation of the excess mortality hazard in case of insufficiently stratified life tables.
Rubio FJ; Rachet B; Giorgi R; Maringe C; Belot A
Biostatistics; 2021 Jan; 22(1):51-67. PubMed ID: 31135884
[TBL] [Abstract][Full Text] [Related]
14. Nonproportional hazards model with a frailty term for modeling subgroups with evidence of long-term survivors: Application to a lung cancer dataset.
Gazon AB; Milani EA; Mota AL; Louzada F; Tomazella VLD; Calsavara VF
Biom J; 2022 Jan; 64(1):105-130. PubMed ID: 34569095
[TBL] [Abstract][Full Text] [Related]
15. Bridged parametric survival models: General paradigm and speed improvements.
Swihart BJ; Bandyopadhyay D
Comput Methods Programs Biomed; 2021 Jul; 206():106115. PubMed ID: 33992900
[TBL] [Abstract][Full Text] [Related]
16. Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.
Esayas Lelisho M; Akessa GM; Kifle Demissie D; Fikadu Yermosa S; Andargie SA; Tareke SA; Pandey D
J Gastrointest Cancer; 2023 Mar; 54(1):104-116. PubMed ID: 35064523
[TBL] [Abstract][Full Text] [Related]
17. A flexible class of generalized joint frailty models for the analysis of survival endpoints.
Chauvet J; Rondeau V
Stat Med; 2023 Apr; 42(8):1233-1262. PubMed ID: 36775273
[TBL] [Abstract][Full Text] [Related]
18. Bayesian cure rate models induced by frailty in survival analysis.
de Souza D; Cancho VG; Rodrigues J; Balakrishnan N
Stat Methods Med Res; 2017 Oct; 26(5):2011-2028. PubMed ID: 28656796
[TBL] [Abstract][Full Text] [Related]
19. On a general structure for hazard-based regression models: An application to population-based cancer research.
Rubio FJ; Remontet L; Jewell NP; Belot A
Stat Methods Med Res; 2019 Aug; 28(8):2404-2417. PubMed ID: 30068256
[TBL] [Abstract][Full Text] [Related]
20. A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data.
Tran TMP; Abrams S; Braekers R
Stat Med; 2020 May; 39(12):1695-1714. PubMed ID: 32129520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
